| Company Name: |
Xi'an Confluore Biological Technology Co., Ltd.
|
| Tel: |
+86-156-80926068 +86-15680926068 |
| Email: |
1924344760@qq.com |
| Products Intro: |
Product Name:azido-PEG7-t-Butyl ester
CAS:2596867-40-0
Purity:98% HPLC Package:10MG;25MG;50MG;100MG;1G;5G Remarks:For customers outside China,please use the website:www.confluore.com
|
| Company Name: |
Zhengzhou convergence chemical co., LTD
|
| Tel: |
0371-0371-55153829 18003835034 |
| Email: |
2853979819@qq.com |
| Products Intro: |
Product Name:N3-PEG7-COOtBu
CAS:2596867-40-0
Purity:98% Package:100mg;500mg;1g;2g;5g;10g;25g;100g;500g;1kg
|
| Company Name: |
Beijing Jin Ming Biotechnology Co., Ltd.
|
| Tel: |
010-60605840 |
| Email: |
psaitong@jm-bio.com |
| Products Intro: |
Product Name:Azido-PEG7-t-butyl ester
CAS:2596867-40-0
Purity:95% Package:100mg;250mg;1g
|
Azido-PEG7-COOtBu manufacturers
|
| | Azido-PEG7-COOtBu Basic information |
| | Azido-PEG7-COOtBu Chemical Properties |
| | Azido-PEG7-COOtBu Usage And Synthesis |
| Biological Activity | Azido-PEG7-t-butyl ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | Azido-PEG7-COOtBu Preparation Products And Raw materials |
|